Overview

Study of Vitamin D3 Substitution to Patients With Primary Immunodeficiency

Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
Hypothesis: Cholecalciferol (vitamin D3) prevent respiratory tract infections in patients with primary immunodeficiency.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Karolinska University Hospital
Treatments:
Cholecalciferol
Ergocalciferols
Vitamin D
Vitamins